Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP710586.RAt6e1ptTvb_mBux2BO0wInZuBaOqa6S1665Yp9o9LEfc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP710586.RAt6e1ptTvb_mBux2BO0wInZuBaOqa6S1665Yp9o9LEfc130_assertion type Assertion NP710586.RAt6e1ptTvb_mBux2BO0wInZuBaOqa6S1665Yp9o9LEfc130_head.
- NP710586.RAt6e1ptTvb_mBux2BO0wInZuBaOqa6S1665Yp9o9LEfc130_assertion description "[On the other hand in case of patients with pre-core/core promoter mutant type CHB, in the moderate to high HBV DNA group, 79.5% (35 patients) had minimal to mild chronic hepatitis (HAI-NI 0-8) and 20.5% (9) had moderate to severe chronic hepatitis (HAI-NI 9-18).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP710586.RAt6e1ptTvb_mBux2BO0wInZuBaOqa6S1665Yp9o9LEfc130_provenance.
- NP710586.RAt6e1ptTvb_mBux2BO0wInZuBaOqa6S1665Yp9o9LEfc130_assertion evidence source_evidence_literature NP710586.RAt6e1ptTvb_mBux2BO0wInZuBaOqa6S1665Yp9o9LEfc130_provenance.
- NP710586.RAt6e1ptTvb_mBux2BO0wInZuBaOqa6S1665Yp9o9LEfc130_assertion SIO_000772 17897910 NP710586.RAt6e1ptTvb_mBux2BO0wInZuBaOqa6S1665Yp9o9LEfc130_provenance.
- NP710586.RAt6e1ptTvb_mBux2BO0wInZuBaOqa6S1665Yp9o9LEfc130_assertion wasDerivedFrom befree-20150227 NP710586.RAt6e1ptTvb_mBux2BO0wInZuBaOqa6S1665Yp9o9LEfc130_provenance.
- NP710586.RAt6e1ptTvb_mBux2BO0wInZuBaOqa6S1665Yp9o9LEfc130_assertion wasGeneratedBy ECO_0000203 NP710586.RAt6e1ptTvb_mBux2BO0wInZuBaOqa6S1665Yp9o9LEfc130_provenance.